HomeCompareEXEO vs MRK

EXEO vs MRK: Dividend Comparison 2026

EXEO yields 400000.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXEO wins by $5.011119029548644e+32M in total portfolio value
10 years
EXEO
EXEO
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full EXEO calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — EXEO vs MRK

📍 EXEO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXEOMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXEO + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXEO pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXEO
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, EXEO beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXEO + MRK for your $10,000?

EXEO: 50%MRK: 50%
100% MRK50/50100% EXEO
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EXEO
No analyst data
Altman Z
-138.6
Piotroski
3/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXEO buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXEOMRK
Forward yield400000.00%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5.011119029548644e+32M$57.7K
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00$10,113.78
Total dividends collected$5.010957816668433e+32M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EXEO vs MRK ($10,000, DRIP)

YearEXEO PortfolioEXEO Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$40,010,700$40,000,000.00$11,213$373.04+$40.00MEXEO
2$149,615,521,729$149,572,710,280.37$12,667$512.06+$149615.51MEXEO
3$522,880,052,725,200$522,719,964,116,949.25$14,439$708.14+$522880052.71MEXEO
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$16,640$988.16+$1707862989289.03MEXEO
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$19,432$1,394.07+$5213509402845684.00MEXEO
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$23,057$1,992.90+$14874219058409543680.00MEXEO
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$27,889$2,894.79+$3.966119623405075e+22MEXEO
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$34,518$4,286.29+$9.88384363503273e+25MEXEO
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$43,912$6,494.35+$2.302052364743449e+29MEXEO
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$57,714$10,113.78+$5.011119029548644e+32MEXEO

EXEO vs MRK: Complete Analysis 2026

EXEOStock

Exeo Entertainment, Inc. designs, develops, licenses, manufactures, and markets consumer electronics in the video gaming, music, and smart TV sector. It develops Psyko 5.1 surround sound gaming headphones for consoles; and Krankz MAXX Bluetooth wireless headphones. The company has license agreements with Psyko Audio Labs Canada to manufacture and distribute the Carbon and Krypton line of patented headphones; and Digital Extreme Technologies, Inc. to design and develop the Extreme Gamer, as well as the Black Widow keyboard. Exeo Entertainment, Inc. was incorporated in 2011 and is based in Las Vegas, Nevada.

Full EXEO Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EXEO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXEO vs SCHDEXEO vs JEPIEXEO vs OEXEO vs KOEXEO vs MAINEXEO vs JNJEXEO vs ABBVEXEO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.